Tempest Therapeutics, Inc. · NASDAQ:TPST
Matthew Angel reported a 35.90% stake in Tempest Therapeutics, Inc. (Schedule 13D)
Event Feb 3, 2026 · Filed Feb 10, 2026
Matthew Angel reported a 35.90% stake in Tempest Therapeutics, Inc., 4,837,070 shares, with active intent on Feb 3, 2026. Filed Feb 10, 2026 (Schedule 13D).
- Stake
- 35.90%
- Shares
- 4,837,070
- Intent
- Active
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Matthew Angel | 35.90% | 4,837,070 |